In an exploration of 2 distinct timeframes in the 21st century, researchers examine the use and concurrent use of medication types among elderly US adults.
|Slideshows|January 13, 2019
7 Survival Tips for Independents
Author(s)Karen Appold
Standing behind the counter and waiting for customers to walk into your pharmacy is not enough to sustain independents in today’s marketplace. Here are some new or unique things independents should consider to ensure survival, says B. Douglas Hoey, RPh, MBA, CEO of the NCPA.
Advertisement
Advertisement
Related to this article
The investigational anti–IL-33 antibody lowered exacerbation rates across all blood eosinophil levels, a benefit current COPD biologics do not offer.
This episode offers a detailed look into the FDA’s recent PCAC meeting and what the future of peptide compounding could lead to for pharmacy professionals.
A study finds children starting continuous glucose monitoring within a month of diagnosis sustained lower hemoglobin A1C than those who started later.
With obesity, muscle loss, and sleep disorders so prominent in postmenopause, providers are now looking into further expansion of GLP-1 use.
Menopause status and symptoms are inconsistently captured in electronic health records, leaving a gap in care for patients.
As midterm elections approach, the pharmacy industry is backing one of its most meaningful bills yet while the current congressional session wanes.
Data found reduced cardiovascular risk with hormone therapy, particularly among Black women and those starting treatment within 10 years of menopause.
Advertisement
Advertisement
Trending on Drug Topics
1
Muscle Preservation Is Key in GLP-1 Therapy for Postmenopausal Women
2
Tozorakimab Reduces COPD Exacerbations in Phase 3 Trials
3
Polypharmacy, Drug Interactions Threaten Older Adults’ Medication Safety
4
Injectable HIV Treatment Beats Daily Pills in Adolescent Trial
5